nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.212	1	CbGbCtD
Abacavir—Infection—Cisplatin—peripheral nervous system neoplasm	0.000652	0.000827	CcSEcCtD
Abacavir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000652	0.000827	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.000822	CcSEcCtD
Abacavir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000647	0.00082	CcSEcCtD
Abacavir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000647	0.00082	CcSEcCtD
Abacavir—Rash—Topotecan—peripheral nervous system neoplasm	0.000646	0.00082	CcSEcCtD
Abacavir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000646	0.000819	CcSEcCtD
Abacavir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000646	0.000819	CcSEcCtD
Abacavir—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000644	0.000817	CcSEcCtD
Abacavir—Cough—Etoposide—peripheral nervous system neoplasm	0.000643	0.000816	CcSEcCtD
Abacavir—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000643	0.000815	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000815	CcSEcCtD
Abacavir—Headache—Topotecan—peripheral nervous system neoplasm	0.000642	0.000814	CcSEcCtD
Abacavir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000641	0.000813	CcSEcCtD
Abacavir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000641	0.000813	CcSEcCtD
Abacavir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000641	0.000813	CcSEcCtD
Abacavir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000641	0.000812	CcSEcCtD
Abacavir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000641	0.000812	CcSEcCtD
Abacavir—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00064	0.000812	CcSEcCtD
Abacavir—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000639	0.00081	CcSEcCtD
Abacavir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000638	0.000809	CcSEcCtD
Abacavir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000638	0.000809	CcSEcCtD
Abacavir—Headache—Tretinoin—peripheral nervous system neoplasm	0.000637	0.000808	CcSEcCtD
Abacavir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000637	0.000808	CcSEcCtD
Abacavir—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000635	0.000805	CcSEcCtD
Abacavir—Pain—Vincristine—peripheral nervous system neoplasm	0.000635	0.000805	CcSEcCtD
Abacavir—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000633	0.000803	CcSEcCtD
Abacavir—Rash—Melphalan—peripheral nervous system neoplasm	0.000633	0.000803	CcSEcCtD
Abacavir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000632	0.000802	CcSEcCtD
Abacavir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.000799	CcSEcCtD
Abacavir—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000795	CcSEcCtD
Abacavir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000626	0.000794	CcSEcCtD
Abacavir—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000792	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000623	0.00079	CcSEcCtD
Abacavir—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00062	0.000786	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000784	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000784	CcSEcCtD
Abacavir—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000614	0.000778	CcSEcCtD
Abacavir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000612	0.000777	CcSEcCtD
Abacavir—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.000776	CcSEcCtD
Abacavir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000609	0.000773	CcSEcCtD
Abacavir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000609	0.000773	CcSEcCtD
Abacavir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000609	0.000772	CcSEcCtD
Abacavir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000607	0.00077	CcSEcCtD
Abacavir—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000607	0.00077	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000767	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000767	CcSEcCtD
Abacavir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000604	0.000766	CcSEcCtD
Abacavir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000604	0.000766	CcSEcCtD
Abacavir—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000602	0.000763	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000598	0.000759	CcSEcCtD
Abacavir—Infection—Etoposide—peripheral nervous system neoplasm	0.000598	0.000758	CcSEcCtD
Abacavir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000596	0.000756	CcSEcCtD
Abacavir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000596	0.000756	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000754	CcSEcCtD
Abacavir—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000748	CcSEcCtD
Abacavir—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000589	0.000747	CcSEcCtD
Abacavir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000587	0.000744	CcSEcCtD
Abacavir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000587	0.000744	CcSEcCtD
Abacavir—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000743	CcSEcCtD
Abacavir—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000742	CcSEcCtD
Abacavir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000584	0.000741	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000737	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000735	CcSEcCtD
Abacavir—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000573	0.000727	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000725	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000725	CcSEcCtD
Abacavir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000571	0.000724	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00057	0.000723	CcSEcCtD
Abacavir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000569	0.000721	CcSEcCtD
Abacavir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00072	CcSEcCtD
Abacavir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000567	0.000719	CcSEcCtD
Abacavir—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000562	0.000713	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.000712	CcSEcCtD
Abacavir—Pain—Cisplatin—peripheral nervous system neoplasm	0.000561	0.000712	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00071	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00071	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000703	CcSEcCtD
Abacavir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.000701	CcSEcCtD
Abacavir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000547	0.000694	CcSEcCtD
Abacavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.000691	CcSEcCtD
Abacavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000541	0.000686	CcSEcCtD
Abacavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00054	0.000685	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000682	CcSEcCtD
Abacavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000536	0.00068	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000678	CcSEcCtD
Abacavir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000533	0.000676	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000674	CcSEcCtD
Abacavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000528	0.00067	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.000669	CcSEcCtD
Abacavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000527	0.000669	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000665	CcSEcCtD
Abacavir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000524	0.000665	CcSEcCtD
Abacavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000523	0.000663	CcSEcCtD
Abacavir—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00052	0.000659	CcSEcCtD
Abacavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000519	0.000659	CcSEcCtD
Abacavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000658	CcSEcCtD
Abacavir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000519	0.000658	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000657	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000654	CcSEcCtD
Abacavir—Pain—Etoposide—peripheral nervous system neoplasm	0.000514	0.000652	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000652	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000651	CcSEcCtD
Abacavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.000646	CcSEcCtD
Abacavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000508	0.000644	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000634	CcSEcCtD
Abacavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000496	0.000629	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000628	CcSEcCtD
Abacavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000494	0.000626	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000624	CcSEcCtD
Abacavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000492	0.000624	CcSEcCtD
Abacavir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000491	0.000623	CcSEcCtD
Abacavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.000621	CcSEcCtD
Abacavir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.000616	CcSEcCtD
Abacavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.000616	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000615	CcSEcCtD
Abacavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000484	0.000614	CcSEcCtD
Abacavir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.000612	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00061	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000608	CcSEcCtD
Abacavir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000478	0.000606	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000605	CcSEcCtD
Abacavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000476	0.000603	CcSEcCtD
Abacavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000476	0.000603	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000603	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000602	CcSEcCtD
Abacavir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000472	0.000599	CcSEcCtD
Abacavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000471	0.000597	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000597	CcSEcCtD
Abacavir—Rash—Vincristine—peripheral nervous system neoplasm	0.000468	0.000594	CcSEcCtD
Abacavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000468	0.000593	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000592	CcSEcCtD
Abacavir—Headache—Vincristine—peripheral nervous system neoplasm	0.000465	0.00059	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000587	CcSEcCtD
Abacavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.000581	CcSEcCtD
Abacavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000449	0.00057	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000449	0.000569	CcSEcCtD
Abacavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000443	0.000562	CcSEcCtD
Abacavir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000441	0.000559	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000557	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000553	CcSEcCtD
Abacavir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000432	0.000547	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000547	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000544	CcSEcCtD
Abacavir—Chills—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00054	CcSEcCtD
Abacavir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000426	0.00054	CcSEcCtD
Abacavir—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000532	CcSEcCtD
Abacavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000417	0.000529	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000527	CcSEcCtD
Abacavir—Rash—Cisplatin—peripheral nervous system neoplasm	0.000414	0.000525	CcSEcCtD
Abacavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000414	0.000525	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000524	CcSEcCtD
Abacavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000412	0.000522	CcSEcCtD
Abacavir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000398	0.000504	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000503	CcSEcCtD
Abacavir—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.0005	CcSEcCtD
Abacavir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00039	0.000495	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000492	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000486	CcSEcCtD
Abacavir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000382	0.000485	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000485	CcSEcCtD
Abacavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000484	CcSEcCtD
Abacavir—Rash—Etoposide—peripheral nervous system neoplasm	0.000379	0.000481	CcSEcCtD
Abacavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000379	0.000481	CcSEcCtD
Abacavir—Headache—Etoposide—peripheral nervous system neoplasm	0.000377	0.000478	CcSEcCtD
Abacavir—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000473	CcSEcCtD
Abacavir—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000471	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000469	CcSEcCtD
Abacavir—Cough—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000457	CcSEcCtD
Abacavir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000454	CcSEcCtD
Abacavir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000357	0.000453	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.00045	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000448	CcSEcCtD
Abacavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000446	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000446	CcSEcCtD
Abacavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000445	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000443	CcSEcCtD
Abacavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000441	CcSEcCtD
Abacavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000437	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000436	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000434	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000428	CcSEcCtD
Abacavir—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000428	CcSEcCtD
Abacavir—Infection—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000425	CcSEcCtD
Abacavir—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000423	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.00042	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000419	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000419	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000415	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000413	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000413	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000411	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00041	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000408	CcSEcCtD
Abacavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000408	CcSEcCtD
Abacavir—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000315	0.0004	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000396	CcSEcCtD
Abacavir—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000396	CcSEcCtD
Abacavir—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000393	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00039	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000388	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000387	CcSEcCtD
Abacavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000387	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000384	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000384	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000381	CcSEcCtD
Abacavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000377	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000372	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00037	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000369	CcSEcCtD
Abacavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000369	CcSEcCtD
Abacavir—Pain—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000366	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000361	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000358	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000355	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000353	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000352	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00035	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000344	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000342	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000341	CcSEcCtD
Abacavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00034	CcSEcCtD
Abacavir—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000338	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000338	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000338	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000326	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000324	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000315	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000314	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000313	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000313	CcSEcCtD
Abacavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000307	CcSEcCtD
Abacavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000303	CcSEcCtD
Abacavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000293	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000292	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000284	CcSEcCtD
Abacavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000283	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00028	CcSEcCtD
Abacavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000272	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000271	CcSEcCtD
Abacavir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000213	0.00027	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000269	CcSEcCtD
Abacavir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000268	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000262	CcSEcCtD
Abacavir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000254	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000252	CcSEcCtD
Abacavir—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000249	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000249	CcSEcCtD
Abacavir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000248	CcSEcCtD
Abacavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000235	CcSEcCtD
